FUJIFILM Cellular Dynamics, Inc

iCell® Sensory Neurons are so chill! 🧊🧊 iPSC-derived human iCell Sensory Neurons mirror human dorsal root ganglion (DRG) behavior by maintaining low spontaneous action potential firing rates in culture for a least 4 weeks. This behavior enables development of in vitro hypersensitization models and pain drug screening. Order your iCell Sensory Neurons today! https://ow.ly/QMPf50Sz8wX #painresearch #neuropathy #analgesics #pain #neuroscience #drugdiscovery #iPSC

Attending #ISSCR2024 in Hamburg, Germany? Join us at our posters to learn how our newly launched iCell® Sensory Neurons can be used for pain and CIPN drug discovery research. Also, see how immune-mediated toxicity can be assessed with co-culture models using our first-to-market, full function human iPSC-derived macrophages. Not at the meeting? Visit our web page to gain access to the posters! https://ow.ly/QbBe50SyeAn #ISSCR2024 #DrugDiscovery #StemCells #ChronicPain #Neuroinflammation #Neuropathy #Neuroscience #iPSC #Immunology #3DCellCulture #Organoids

Hurry - Don't miss out! Join innoVitro's LabINAR Break webinar series where FUJIFILM Cellular Dynamics' Dr. Ravi Vaidyanathan, PhD will present the benefits of building relevant 2D and 3D cardiac co-cultures models using iCell® products to propel your drug discovery screening programs. Date: Wednesday, July 10 Time: 4 PM CEST • 10 AM EST • 7 AM PST ⭐It's not too late - REGISTER NOW! https://ow.ly/STZe50Subvh #CardiacModels #DrugDiscovery #InnoVitro #StemCells #iPSC #Fibroblasts

🔥 Speed up your pain drug discovery pipelines! iCell Sensory Neurons are human iPSC-derived cells that offer a short culture-to-assay timeframe. These neurons have consistent well-to-well responses to TRPV1, P2X3 and TRPM8 agonists by 3 weeks post-plating. This short culture duration and reproducible assay performance make these neurons ideal for high through-put compound testing. Try iCell Sensory Neurons today! https://ow.ly/ltfa50StWbv #ChronicPain #Neuroinflammation #DrugDiscovery #Neuropathy #Neuroscience #iPSC #StemCells

💥💥NEW PRODUCT LAUNCH! We are excited to announce that iCell® Sensory Neurons are now available off-the-shelf. This highly pure population of human iPSC-derived sensory neurons express nociceptor-specific channels and respond to sensory stimuli (capsaicin, ATP, menthol). iCell Sensory Neurons have demonstrated hypersensitivity and cytotoxicity to chemotherapeutic drugs, making them ideal for pain and chemotherapy-induced peripheral neuropathy (CIPN)-related research. ✔️Order your cells now! iCell Sensory Neurons Kit, 01279 (male donor): https://ow.ly/XZbt50SpgJ4 iCell Sensory Neurons Kit, 21527 (female donor): https://ow.ly/zhQT50SpgJ6

#Neuroscience research has traditionally relied on primary neuronal cell cultures, which can be limited and challenging to work with. This is particularly critical in drug discovery for neurodegenerative diseases, where robust and scalable models are essential. Stem cell-derived neurons, particularly human iCell® Neurons, offer a scalable solution, addressing the limitations of primary cell cultures. These neurons provide a physiologically relevant environment for studying human drug targets in terminally differentiated, postmitotic cells. At Nanion Technologies, in collaboration with FUJIFILM Cellular Dynamics, Inc, we have prepared an 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗡𝗼𝘁𝗲 that may interest researchers working in neuroscience drug discovery. Here are a few highlights from this AppNote: ◾ Human iPSC-derived neurons, such as iCell® Neurons, offer a scalable, flexible, and cost-effective solution for neuroscience research. ◾ These neurons were successfully utilized on the Patchliner, facilitating detailed electrophysiological studies. The Patchliner’s capabilities allowed for simultaneous recording from multiple cells, providing robust data. ◾ iCell® Neurons express key ion channels, including NaV, KV, and GABAA receptors, and demonstrate electrophysiological properties aligning closely with those observed in manual patch clamp studies, providing reliable data for neurotoxicity, disease research, and drug discovery. ➡ For full details, 𝗱𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗼𝘂𝗿 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗻𝗼𝘁𝗲 here: https://lnkd.in/gAqK7PYq #Neuroscience #DrugDiscovery #hiPSC #IonChannels #iPSC #neurons #PatchClamp

⭐ Thaw, plate, assay! iCell Microglia offer the shortest thaw-to-assay time⏱️ in the industry enabling you to cycle through pivotal experiments with speed while using a highly consistent human iPSC-based model. ORDER TODAY! https://ow.ly/UutH50Si1J1 #DrugDiscovery #iPSC #StemCells #Microglia #CellBasedAssays #Phagocytosis #Neuroscience #Inflammation

FUJIFILM Cellular Dynamics Announces License Agreement with Tome Biosciences for the Development of iPSC-Derived Cell Therapies. MADISON, WIS., June 5, 2024 -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSCs), announced today that it has entered an agreement to grant Tome Biosciences, Inc. (“Tome”), the programmable genomic integration (PGI) company, a non-exclusive right to use FUJIFILM Cellular Dynamics’ iPSC platform for the development and commercialization of iPSC-derived cell therapies. Under the agreement, Tome will have a non-exclusive license to use the iPSC cell lines for research and development purposes, and to utilize GMP-grade cell lines for manufacturing and commercialization of iPSC-derived cell therapies. Over the past few years FUJIFILM Cellular Dynamics has licensed its iPSC platform to numerous leading biotech companies including Novo A/S, Sana Biotechnology, IASO Biotherapeutics, Cynata Therapeutics among others. #iPSC #StemCells #CellTherapies

“Fujifilm is excited to join the premier biotech industry event to showcase our talent and experience in life sciences as we meet with innovators and demonstrate how our life science solutions can offer current and future customers support in advancing therapies.” - Toshihisa Iida, Corporate VP, GM, Life Sciences Strategy Headquarters, FUJIFILM Corporation Stop by combined booth 5035/4835 during #BIO2024 where Fujifilm will spotlight an expansive portfolio of #lifesciences innovations and expertise as well as host 8 in-booth presentations from the brightest minds in the industry. See the full speaker schedule and learn more here: https://brnw.ch/21wKhcT

🌎Excited for BIO International Convention next week! Visit us at the FUJIFILM Pavilion, Booth 5035/4835 on June 4th at 1 pm where Dr. Keith Olson, our Executive Vice President, Commercial, will be speaking on "Leveraging Human iPSCs for Therapeutic and Drug Discovery Applications". Learn how as the leader in stem cell technology, FUJIFILM Cellular Dynamics is dedicated to developing innovative research tools to propel drug discoveries and cell therapies. 💡Interested in learning how FUJIFILM Cellular Dynamics can help you achieve your research goals quicker through the use of iPSC and iPSC-derived cell types? Be sure to schedule time with Dr. Eugenia (Genie) Jones, VP, Development and Partnerships, through the BIO One-on-One Partnering Portal or stop by the booth. #BIO2024 #StemCells #iPSCs #DrugDiscovery #BioConvention